Mechanisms of antibiotic resistance in Pseudomonas aeruginosa

Journal of the Royal Society of Medicine, Supplement

Volumn 95, Issue 41, 2002, Pages 22-26

  Lambert, P A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN DERIVATIVE; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL OUTER MEMBRANE; BIOFILM; CONFERENCE PAPER; CYSTIC FIBROSIS; DRUG INACTIVATION; DRUG PENETRATION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; CELL WALL; DRUG RESISTANCE, BACTERIAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0036290198     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria
2. Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test
3. Survey of antimicrobial resistance of Pseudomonas aeruginosa isolates from cystic fibrosis patients in the United Kingdom
4. Inhibition of tobramycin diffusion by binding to alginate
5. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: Antibiotic resistance, β-lactamase activity and Riboprinting
6. The amino terminus of Pseudomonas aeruginosa outer membrane protein OprF forms channels in lipid bilayer membranes: Correlation with a three-dimensional model
7. Of Pseudomonas, porins, pumps and carbapeanems
8. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa
9. Multiple antibiotic resistance and efflux
10. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms
11. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM
12. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains
13. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment
14. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains
15. Beta-lactamase inhibitors: Agents to overcome bacterial resistance
16. Inhibitor-resistant TEM beta-lactamases: Phenotypic, genetic and biochemical characteristics
17. Carbapenemase-producing Pseudomonas aeruginosa in UK
18. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment
19. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: Role of target enzyme in mechanism of fluoroquinolone resistance
20. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa
21. Antibiotic resistance of bacteria in biofilms
22. Mechanisms of biofilm resistance to antimicrobial agents
23. N-Acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms